Form 4: Hanover Insurance Group CEO John Roche Reports Stock Transactions Following Vesting of Performance-Based Restricted Stock Units

John Roche, President and CEO of Hanover Insurance Group, reports acquisition and disposal of company stock following the vesting of performance-based restricted stock units and the grant of new restricted stock units.

Summary

• On February 26, 2024, John Roche, the President and CEO of Hanover Insurance Group, acquired 9,120 shares of common stock related to performance-based restricted stock units (PBRSUs) that vested at 112% of the target award.
• He also acquired 6,322 shares of common stock related to PBRSUs that vested at 72.73% of the target award on the same date.
• Additionally, 11,233 shares were disposed of to cover withholding taxes upon the vesting of these restricted stock units at a price of $134.61 per share.
• On February 27, 2024, Roche acquired 9,311 restricted stock units under the 2022 Long-Term Incentive Plan, which will vest on the third anniversary of the grant date.
• Roche also acquired 41,437 common stock options (right to buy) at $134.26 on February 27, 2024, which vest in thirds on the first three anniversaries of the grant date.
• Following these transactions, Roche directly owns 113,446.067 shares of common stock and 41,437 common stock options.
• This does not include 7,652 shares held by Roche's spouse.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The vesting of performance-based awards suggests the company met some performance targets. The grant of new equity awards indicates continued confidence in the executive team.

Positives

• The vesting of PBRSUs at above target (112%) suggests strong performance relative to the specified metrics.
• The grant of new restricted stock units and stock options aligns management's interests with those of shareholders.

Negatives

• The disposal of shares to cover withholding taxes reduces Roche's overall holdings, although this is a standard practice.

Risks

• Future performance may not meet the targets required for vesting of the newly granted restricted stock units.
• Market fluctuations could impact the value of the stock options.

Future Outlook

The document details the vesting of previous performance-based awards and the grant of new awards that are contingent on future performance and continued employment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of key executives and their alignment with shareholder interests.

Comparison to Industry Standards

• Equity compensation practices, such as granting restricted stock units and stock options, are standard across the insurance industry and among publicly traded companies to incentivize executives.
• The vesting schedules and performance metrics associated with these awards are typically aligned with long-term value creation for shareholders.
• Comparable companies like Travelers Companies (TRV) and Chubb (CB) also utilize similar equity compensation plans for their executives.

Stakeholder Impact

• The transactions have a minor impact on shareholders, as they reflect standard executive compensation practices.
• Employees may be indirectly affected by the performance-based vesting of the awards, as it reflects the company's overall performance.

Next Steps

• The newly granted restricted stock units will vest on the third anniversary of the grant date.
• The stock options vest in thirds on the first three anniversaries of the grant date.

Key Dates